ImmuCell Corporation Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
ImmuCell Corporation (ICCC) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of $513.29 thousand for the 3-month period ending 2022-03-31, per its 10-Q/A filed 2022-11-21.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2022-11-21
- ImmuCell Corporation net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-03-31 was $513.29K.
- ImmuCell Corporation net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2021-03-31 was -$441.30K.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filed |
|---|---|---|
| 2022-03-31 | $513.29K 10-Q/A · filed 2022-11-21 | $735.67K 10-Q · filed 2022-05-12 |
| 2021-03-31 | -$441.30K 10-Q/A · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |